Your browser doesn't support javascript.
loading
Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group.
Pavlinac, Patricia B; Rogawski McQuade, Elizabeth T; Platts-Mills, James A; Kotloff, Karen L; Deal, Carolyn; Giersing, Birgitte K; Isbrucker, Richard A; Kang, Gagandeep; Ma, Lyou-Fu; MacLennan, Calman A; Patriarca, Peter; Steele, Duncan; Vannice, Kirsten S.
Affiliation
  • Pavlinac PB; Departments of Global Health and Epidemiology, University of Washington, Seattle, WA 98105, USA.
  • Rogawski McQuade ET; Department of Epidemiology, Emory University, Atlanta, GA 30322, USA.
  • Platts-Mills JA; Department of Medicine, Infectious Diseases and International Health, University of Virginia, Charlottesville, VA 22908, USA.
  • Kotloff KL; Department of Pediatrics, Medicine, Epidemiology, and Public Health, University of Maryland, Baltimore, MD 21201, USA.
  • Deal C; Enteric and Sexually Transmitted Infections Branch, National Institutes of Health, Rockvile, MD 20892, USA.
  • Giersing BK; Immunization, Vaccines, and Biologicals Department, World Health Organization, 1211 Geneva, Switzerland.
  • Isbrucker RA; Immunization, Vaccines, and Biologicals Department, World Health Organization, 1211 Geneva, Switzerland.
  • Kang G; Department of Gastrointestinal Sciences, Christian Medical College, Vellore 632004, Tamil Nadu, India.
  • Ma LF; Enteric and Diarrheal Diseases Program Strategy Team, Bill & Melinda Gates Foundation, Seattle, WA 98102, USA.
  • MacLennan CA; Enteric and Diarrheal Diseases Program Strategy Team, Bill & Melinda Gates Foundation, Seattle, WA 98102, USA.
  • Patriarca P; Bill & Melinda Gates Medical Research Institute, Cambridge, MA 02139, USA.
  • Steele D; Enteric and Diarrheal Diseases Program Strategy Team, Bill & Melinda Gates Foundation, Seattle, WA 98102, USA.
  • Vannice KS; Enteric and Diarrheal Diseases Program Strategy Team, Bill & Melinda Gates Foundation, Seattle, WA 98102, USA.
Vaccines (Basel) ; 10(4)2022 Mar 22.
Article in En | MEDLINE | ID: mdl-35455238

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Vaccines (Basel) Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Vaccines (Basel) Year: 2022 Type: Article Affiliation country: United States